Fingolimod and Dimethyl-Fumarate-Derived Lymphopenia is not Associated with Short-Term Treatment Response and Risk of Infections in a Real-Life MS Population

被引：0
|
作者：
Giacomo Boffa
Nicolò Bruschi
Maria Cellerino
Caterina Lapucci
Giovanni Novi
Elvira Sbragia
Elisabetta Capello
Antonio Uccelli
Matilde Inglese
机构：
[1] University of Genoa,Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DINOGMI)
[2] Ospedale Policlinico San Martino IRCCS,undefined
来源：
CNS Drugs | 2020年 / 34卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：425 / 432
页数：7
相关论文
共 9 条
  • [1] Fingolimod and Dimethyl-Fumarate-Derived Lymphopenia is not Associated with Short-Term Treatment Response and Risk of Infections in a Real-Life MS Population
    Boffa, Giacomo
    Bruschi, Nicolo
    Cellerino, Maria
    Lapucci, Caterina
    Novi, Giovanni
    Sbragia, Elvira
    Capello, Elisabetta
    Uccelli, Antonio
    Inglese, Matilde
    CNS DRUGS, 2020, 34 (04) : 425 - 432
  • [2] Fingolimod and dimethyl-fumarate derived lymphopenia is not associated with short-term treatment response and risk of infections in a real-life MS population
    Bruschi, N.
    Boffa, G.
    Cellerino, M.
    Lapucci, C.
    Novi, G.
    Sbragia, E.
    Capello, E.
    Uccelli, A.
    Inglese, M.
    EUROPEAN JOURNAL OF NEUROLOGY, 2020, 27 : 201 - 201
  • [3] Lymphopenia is not associated with efficacy and risk of adverse events in a real-life MS population treated with fingo-limod and dimethyl fumarate
    Bruschi, N.
    Boffa, G.
    Cellerino, M.
    Sbragia, E.
    Novi, G.
    Lapucci, C.
    Carpaneto, S.
    Laroni, A.
    Capello, E.
    Uccelli, A.
    Inglese, M.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 334 - 334
  • [4] First ever treatment in MS: fingolimod vs dimethyl fumarate, the Lausanne real-life experience
    Pantazou, V.
    Pot, C.
    Du Pasquier, R.
    Theaudin, M.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 544 - 545
  • [5] Short-term attentional perseveration associated with real-life creative achievement
    Zabelina, Darya L.
    Beeman, Mark
    FRONTIERS IN PSYCHOLOGY, 2013, 4
  • [6] A multicentre, real-life study on the risk of lymphopenia and infections discloses a favourable safety profile of cladribine in ms patients
    Margoni, M.
    Annovazzi, P.
    Prosperini, L.
    Capuano, R.
    Gallo, A.
    Frau, J.
    Cocco, E.
    Nozzolillo, A.
    Moiola, L.
    Capobianco, M.
    Zaffaroni, M.
    Perini, P.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 252 - 252
  • [7] Short-term dynamic thermal perception and physiological response to step changes between real-life indoor and outdoor environments
    Jiang, Ying
    Xie, Yongxin
    Niu, Jianlei
    BUILDING AND ENVIRONMENT, 2024, 251
  • [8] Evaluation of short-term (16-week) effectiveness and safety of guselkumab in patients with psoriasis: A prospective real-life study on the Chinese population
    Zhuang, Jia-Yi
    Li, Jin-Sheng
    Zhong, Yuan-Qiu
    Zhang, Fang-Fei
    Li, Xin-Ze
    Su, Hang
    Zhang, Ze-Qiao
    Wang, Xiao-Hua
    Chen, Yong-Feng
    DERMATOLOGIC THERAPY, 2021, 34 (05)
  • [9] Short-term safety and efficacy of switching from alemtuzumab to ocrelizumab in MS patients with disease activity after two alemtuzumab courses: an Italian multicentric, real-life study.
    Lapucci, C.
    Frau, J.
    Cocco, E.
    Vercellino, M.
    Cavalla, P.
    Petracca, M.
    Lanzillo, R.
    Grossi, P.
    Ferro, M. T.
    Guaschino, C.
    Zaffaroni, M.
    Tazza, F.
    Novi, G.
    Uccelli, A.
    Inglese, M.
    EUROPEAN JOURNAL OF NEUROLOGY, 2020, 27 : 929 - 929
1